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Abstract
Background:  Erythrocyte invasion by Plasmodium falciparum parasites represents a key
mechanism during malaria pathogenesis. Erythrocyte binding antigen-181 (EBA-181) is an important
invasion protein, which mediates a unique host cell entry pathway. A novel interaction between
EBA-181 and human erythrocyte membrane protein 4.1 (4.1R) was recently demonstrated using
phage display technology. In the current study, recombinant proteins were utilized to define and
characterize the precise molecular interaction between the two proteins.
Methods: 4.1R structural domains (30, 16, 10 and 22 kDa domain) and the 4.1R binding region in
EBA-181 were synthesized in specific Escherichia coli strains as recombinant proteins and purified
using magnetic bead technology. Recombinant proteins were subsequently used in blot-overlay and
histidine pull-down assays to determine the binding domain in 4.1R.
Results: Blot overlay and histidine pull-down experiments revealed specific interaction between
the 10 kDa domain of 4.1R and EBA-181. Binding was concentration dependent as well as saturable
and was abolished by heat denaturation of 4.1R.
Conclusion: The interaction of EBA-181 with the highly conserved 10 kDa domain of 4.1R
provides new insight into the molecular mechanisms utilized by P. falciparum during erythrocyte
entry. The results highlight the potential multifunctional role of malaria invasion proteins, which
may contribute to the success of the pathogenic stage of the parasite's life cycle.
Background
Malaria is caused by a group of infectious protozoan par-
asites that alters the physiological functioning and cellular
biology of erythrocytes. Plasmodium falciparum is the best-
studied species and is the commonest, most virulent and
principal cause of the majority of infections and deaths
worldwide. Since the completion of the parasite's genome
sequence [1], a wealth of knowledge has been generated
through proteomic and genomic studies. High-through-
put screening [2,3], protein identification technology
such as mass spectrometry [4-7] and gene knockdown/
knockout technology [8-13] are some of the methods that
have been used to decipher complex molecular processes
governing the life cycle of P. falciparum.
The invasion of erythrocytes by P. falciparum initiates the
pathogenic phase of the life cycle and is essential for par-
asite survival and progression of clinical malaria [14].
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Invasion is a complex process involving a series of molec-
ular interactions between P. falciparum merozoites and
erythrocyte membrane receptors. Mediators of invasion
have been identified on the merozoite surface and in
organelles of the apical complex, namely rhoptries, micro-
nemes and dense granules. However, the precise function-
ing of these proteins and mechanisms governing the entry
process are poorly understood [15,16].
A family of erythrocyte Duffy binding-like (DBL) proteins,
located within the micronemes, plays a crucial role in the
binding of merozoites to the host cell. In P. falciparum, six
homologous DBL genes have been found, including
erythrocyte binding antigen-175 (EBA-175), EBA-181
(JESEBL), EBA-140 (BAEBL), EBA-165 (PEBL), MAEBL
and erythrocyte binding ligand-like 1 protein. These genes
encode several domains including two cysteine-rich
regions. These regions comprise one or two copies of an
amino DBL domain which defines the erythrocyte-bind-
ing region and a C-terminal domain of unknown function
[17]. Each protein encodes unique receptor specificity,
which allows P. falciparum to diversify the number of inva-
sion pathways [18].
EBA-181 has been identified on chromosome 1 of the P.
falciparum genome. The protein is expressed in merozoites
as well as schizonts and evidence suggests that this ligand
plays a role during erythrocyte invasion [19,20]. Eight
polymorphisms have been found in the erythrocyte bind-
ing domains, which have been hypothesized to promote
survival advantage in parasites exposed to genetically
diverse human populations [21].
Recent work utilizing P. falciparum phage display libraries
has identified a protein-protein interaction between
erythrocyte membrane protein 4.1 (4.1R) and EBA-181
[22,23]. 4.1R is an important component of the erythro-
cyte skeleton, which provides mechanical strength to the
membrane through vertical interaction with glycophorin
C/D and horizontal association with spectrin and actin
[24]. The interaction of 4.1R with EBA-181 suggests a new
role for this protein at the host-parasite interface. In this
study, recombinant proteins were used to map the
domain in 4.1R responsible for binding to the parasite
protein.
Methods
Preparation of recombinant proteins
Total RNA was extracted from human reticulocytes [25]
and the four structural domain sequences of 4.1R (30
kDa, 16 kDa, 10 kDa and 22/24 kDa, Figure 1A) [26-28]
were reverse transcribed using AMV reverse transcriptase
(Promega, USA). Primers flanking the relevant domains
were designed and restriction sites for BamH I or EcoR I
and Xho I appended at the 5' and 3' ends respectively
(Table 1). The 4.1R cDNA was amplified by polymerase
chain reaction (PCR), digested with appropriate restric-
tion enzymes and subcloned into the pGEX-4T-2 protein
expression vector (Amersham Biosciences, UK) according
to standard methods. The reading frame and PCR product
sequences were verified using automated DNA sequenc-
ing. 4.1R vector constructs were transfected into Rosetta™
2 (DE3) Escherichia coli (E. coli) cells (Novagen, USA) and
expression of glutathione-S-transferase (GST)-tagged
polypeptides induced with either 1 mM isopropyl β-D-
thiogalactopyranoside (IPTG) (Invitrogen, USA) or Over-
night Express™ Autoinduction System (Novagen, USA).
GST-tagged proteins were purified from E. coli extracts
using MagneGST™ agarose beads (Promega, USA).
A histidine (6His)-tagged peptide (denoted PfJ) encom-
passing the 4.1R binding region in EBA-181 was prepared
(Figure 1C). P. falciparum was cultured in vitro by the
method of Trager and Jensen [29] and genomic DNA
extracted using phenol-chloroform and ethanol precipita-
tion. The EBA-181 binding sequence was amplified from
parasite DNA by PCR, using primers containing 5' Nde I
and 3' BamH I recognition sequences (Table 1). PfJ was
subcloned into pET15b vector (Novagen, USA), the insert
sequenced and the vector construct transfected into BL21-
CodonPlus® (DE3) RIL competent cells (Stratagene, USA).
6His-PfJ was induced using 1 mM IPTG and purified from
E. coli extracts using His-Select™ magnetic agarose beads
(Sigma, USA).
Recombinant proteins were dialyzed against PBS (10 mM
Na2HPO4, 1.5 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl,
pH 7.4) in a Slide-A-Lyzer MINI dialysis unit (Pierce,
USA) for 2 hrs at 8°C. Protein concentrations were deter-
mined spectrophotometrically at 595 nm using the
Coomassie Plus® Protein Assay Reagent Kit (Pierce, USA).
Protein aliquots were analyzed by 12% sodium dodecyl
sulphate polyacrylamide gel electrophoresis (SDS-PAGE)
and samples stored at -20°C in a final concentration of 1
mM Pefablock® SC (Roche, Germany).
Blot overlay assays
Blot overlay assays were used for studying protein-protein
interactions between recombinant proteins. The objective
was to map the interaction between 6His-PfJ and GST-
4.1R domains.
Approximately 5 μg of GST, GST-4.1R structural domains
and 6His-parasite protein were spotted onto Hybond C
nitrocellulose membrane strips (Amersham, UK). Addi-
tional binding sites were blocked in 5% BSA in TBS (0.05
M Tris-HCl, 0.9% NaCl, pH 7.5) for 1 hr and the mem-
branes overlaid with 0.5–1 μg of either purified 4.1R [30]
or appropriate recombinant domain for 2 hrs. GST and
the 4.1R domains served as negative and positive controlsMalaria Journal 2006, 5:100 http://www.malariajournal.com/content/5/1/100
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respectively. The strips were washed twice for 1 minute
each in TBS and the bound protein fixed to the membrane
with 0.5% (v/v) formaldehyde in TBS for 20 minutes.
Membranes were washed for 15 minutes in TBS and
probed with 1:1,000 rabbit anti-4.1R antibody (St. Eliza-
beth's Medical Centre, Boston, USA) for at least 1 hr.
Interactions were detected with 1:1,000 goat anti-rabbit
IgG peroxidase conjugated antibody (Roche, Germany)
using Supersignal® West Pico Chemiluminescent substrate
(Pierce, USA).
Pull-down assays
Pull-down assays were used to verify the interaction
between  P. falciparum protein and the specific 4.1R
domain. Furthermore, the dependence of the interaction
Schematic representation of 4.1R and EBA-181 and purification of the respective fusion proteins Figure 1
Schematic representation of 4.1R and EBA-181 and purification of the respective fusion proteins. (A) Schematic 
of 4.1 cDNA showing alternative and constitutive exons. The erythrocyte translation initiation site is indicated at nucleotide 
(nt) position 816 in exon 4 with the coding sequence extending to position 2737. The corresponding full-length 80 kDa-4.1R 
molecule is shown below the cDNA. Amino acid (aa) residue numbers depict the relative locations of the four 4.1R structural 
domains [26-28]. The 30 kDa domain (aa 1–297) is located at the N-terminal end of the protein and corresponds to nt 816–
1716. The 16 kDa and 10 kDa domains are encoded by nt 1717–2285 (aa 298–471), with the 22 kDa region situated at the C-
terminal end. (B) GST-4.1R fusion domains were expressed and purified using glutathione magnetic affinity beads. Approxi-
mately 1–2 μg of total protein was resolved by 12% SDS-PAGE. The protein samples are erythrocyte membrane marker M 
(lane 1), GST control (lane 2), GST-10 kDa (lane 3), GST-16 kDa (lane 4), GST-22 kDa (lane 5) and GST-30 kDa (lane 6). (C) 
Schematic of the full-length P. falciparum invasion protein EBA-181 [43], accession number: PFA0125c. Amino acid (aa) num-
bers underneath the schematic demarcate the various domains in the protein. The molecule comprises two DBL domains 
(denoted F1 and F2) which define erythrocyte specificity, as well as two transmembrane regions and a C-terminal cysteine-rich 
motif. The relative position of the EBA-181 fragment (PfJ) used in this study is shown (aa 945–1097; expected size 25 kDa). (D) 
6His-PfJ was expressed and purified from crude E. coli lysates using magnetic nickel beads and resolved by SDS-PAGE: M, eryth-
rocyte membrane marker (lane 1) and purified PfJ (lane 2), which resolves at ~50 kDa.Malaria Journal 2006, 5:100 http://www.malariajournal.com/content/5/1/100
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on concentration was determined by densitometric scan-
ning of 12% SDS-PAGE gels.
Approximately 700 ng 6His-PfJ was coupled to 30 μl aliq-
uots of His-Select™ magnetic beads. Various amounts of
specific GST-4.1R domain, ranging from 150 ng to 2 μg, as
well as 0.5 μg, 5 μg and 10 μg heat denatured protein were
added to the beads and incubated for 1 hr at room tem-
perature. The denatured samples served as a control to
correct for non-specific binding. The beads were rinsed
with TBS and the protein complexes eluted using 1% SDS
in TBS for 10 minutes. Samples were analyzed by SDS-
PAGE and 12% polyacrylamide gels scanned using a
Hoefer transmittance/reflectance scanning densitometer
(Hoefer, USA). Areas under the peaks were compared to
standard GST-10 kDa and 6His-PfJ curves and the ratio of
bound protein (μg) to parasite protein (μg) determined. A
curve was plotted against the amount of 4.1R domain to
determine whether the interaction was saturable.
Results and discussion
Recombinant proteins
Rosetta 2 (DE3) cells were transformed with the different
4.1R domain constructs and induced with 1 mM IPTG.
Under these conditions, the expressed 10 kDa, 16 kDa
and 22 kDa recombinant proteins were soluble, while the
GST-tagged 30 kDa protein was completely insoluble. The
use of the Overnight Express™ Autoinduction system sig-
nificantly improved the yield of soluble GST-30 kDa. 0.5–
1 μg of purified protein was obtained from 1 ml IPTG-
induced culture volumes or 25 ml Overnight Express cul-
tures. Scanning densitometry of a 12% SDS polyacryla-
mide gel revealed that purified proteins were more than
85% pure (Figure 1B). A Western blot was performed to
confirm the identity of GST-tagged 4.1R domains (data
not shown). 6His-PfJ was expressed predominantly as a
soluble protein as evidenced by SDS-PAGE analysis and
its identity confirmed with Western blot analysis (data not
shown). Approximately 0.8 μg of protein was obtained
from 1 ml E. coli culture. 6His-PfJ was purified to more
than 95% homogeneity as determined by scanning densi-
tometry. Polyacrylamide gels indicated that PfJ migrated
as an apparent dimer (~50 kDa) under SDS-PAGE condi-
tions (Figure 1D). This is most likely attributed to the high
proportion of charged amino acids in PfJ, which presum-
ably resulted in atypical binding of SDS molecules leading
to aberrant and unpredictable migration patterns on
denaturing polyacrylamide gels [31].
6His-PfJ binds the 10 kDa domain of 4.1R
Recombinant proteins were used in blot overlay and his-
tidine pull-down assays to determine the binding site in
4.1R specific for 6His-PfJ. Blot overlay assays showed that
6His-PfJ bound specifically to the GST-10 kDa domain as
well as native 4.1R (Figure 2). The recombinant parasite
protein did not bind GST nor the 16 kDa, 22 kDa and 30
kDa GST-tagged domains. To confirm the interaction
between GST-4.1R fragments and 6His-PfJ, histidine pull-
down assays were performed. In agreement with the blot
overlay data, GST-10 kDa bound specifically to 6His-PfJ in
a dose-dependent manner (Figure 3A). The interaction
was abolished by heat denaturation of the 10 kDa
domain. Histidine pull-down assays were also performed
with GST-16, 22 and 30 kDa proteins and 6His-PfJ. As
shown in figure 3B, no binding was detectable in the 30
and 22 kDa reactions. The GST-16 kDa pull-down assay
revealed some binding with 6His-PfJ, but this was non-
specific as the interaction was comparable to heat-dena-
tured 4.1R domain.
To determine whether the interaction between 6His-PfJ
and GST-10 kDa was saturable, the parasite protein was
incubated with a concentration range of 10 kDa domain.
Scanning densitometry of the polyacrylamide gels
revealed that the interaction was concentration dependent
and saturable in three independent experiments using dif-
ferent protein preparations (Figure 4A–C). To compensate
for non-specific binding, 54 ng heat denatured GST-10
kDa per μg 6His-PfJ was subtracted from the amount of
bound protein. This value was determined by averaging
the non-specific binding displayed by 0.5 μg and 10 μg of
heat denatured 4.1R domain, which was 51 and 58 ng/μg
PfJ respectively. This result demonstrated that 6His-PfJ
bound specifically to GST-10 kDa. To allow semi-quanti-
tative assessment of the interaction, a rough estimate of
the dissociation constant (Kd) was obtained by linear
transformations of the three curves which gave an average
Kd of 745 nM.
P. falciparum and erythrocyte invasion proteins
The in vitro association of EBA-181 with an underlying
erythrocyte skeletal protein has important implications
Table 1: Oligonucleotide primers
Domain PCR primer (5'-3') RE
10 kDa F: catgggatcctggaagaaaaagagagaaag BamH I
R: catgctcgagtcagggtgagtgagtggataag Xho I
16 kDa F: catgggatcctttcgatacagtggccggact BamH I
R: catgctcgagtcatgcttctgtgggctctggct Xho I
22 kDa F: catgggatccttccgaactcttaacatcaatgggcaaa BamH I
R: catgctcgagtcactcatcagcaatctcggtctcc Xho I
30 kDa F: catggaattcatgcactgcaaggtttctttgt EcoR I
R: catgctcgagtcatttggatcctagcgcaag Xho I
PfJ F: catgcatgcatatgcctgaagtagttccacaagaa Nde I
R: catgggatccttatgcactttcacctccccc BamH I
Forward (F) and reverse (R) primer sequences were designed for 
amplifying the different human 4.1R domain sequences and P. 
falciparum 4.1R binding sequence (PfJ) in EBA-181. Endonuclease 
recognition sequences are underlined and the corresponding 
restriction enzyme (RE) indicated.Malaria Journal 2006, 5:100 http://www.malariajournal.com/content/5/1/100
Page 5 of 9
(page number not for citation purposes)
for P. falciparum invasion. 4.1R is a critical component of
the erythrocyte skeleton. It functions by stabilizing hori-
zontal protein interactions and links the underlying skel-
eton to the lipid bilayer [32]. The conserved 10 kDa
domain of 4.1R interacts with a number of key proteins,
and represents a pivotal point in the control of erythrocyte
membrane integrity. The domain facilitates the interac-
tion between spectrin and actin, and in so doing main-
tains the deformability of the erythrocyte [24]. The 10 kDa
region has been shown to bind and regulate myosin activ-
ity [33]. Fowler and colleagues [34] proposed that eryth-
rocyte myosin could function together with actin and its
associated proteins in an actomyosin contractile appara-
tus, raising the possibility of an ATP-dependent process
responsible for regulating shape transformations in
human erythrocytes. Cibert and colleagues [35] explored
a potential role for actomyosin complexes in the restora-
tion of erythrocyte membrane skeletons, damaged by
mechanical or chemical stress. Their model proposes that
upon disruption of the skeletal network, cytosolic myosin
is relocated to the erythrocyte bilayer where formation of
an actomyosin complex initiates repair of the relevant
area. The repair process was suggested to involve a stable
linkage of actin protofilaments by myosin filaments
around the area of damage. The disruption of linkages
between 4.1R, spectrin, actin and myosin, therefore, has
serious consequences for the stability and repair of eryth-
rocyte membranes.
Damage inflicted by invading merozoites to the erythro-
cyte's protein and lipid bilayer, may initiate actomyosin
repair processes. This would subsequently lead to the res-
toration of the damaged areas and provide a barrier for
merozoite entry. P. falciparum, having sustained a long-
standing association with human hosts, evolved complex
evolutionary adaptations to ensure its own survival. It
may be conceivable that specific P. falciparum proteins
evolved to subvert host membrane repair. The interaction
between EBA-181 and the 10 kDa domain of 4.1R may be
such a mechanism, whereby EBA-181 blocks the binding
of myosin to 4.1R. This prevents the activation of actomy-
osin repair machinery. As a result, the parasite modulates
host cellular processes to guarantee successful invasion.
Binding of the P. falciparum invasion protein, EBA-181, to
4.1R may thus facilitate invasion and prevent repair of the
damage to the erythrocyte membrane, prior to parasite
entry. Based on published findings from other groups and
the EBA-181/4.1R interaction described in this work, the
following speculative model of P. falciparum erythrocyte
Blot overlay assays of 6His-PfJ with native 4.1R and GST-tagged 4.1R domains Figure 2
Blot overlay assays of 6His-PfJ with native 4.1R and GST-tagged 4.1R domains. The headings above each Western 
blot represent the proteins spotted on the nitrocellulose membrane. Glutathione-S-transferase (GST) and the relevant 4.1R 
domain served as negative and positive controls respectively. The membranes were overlaid with native 4.1R (4.1R overlay) and 
GST-tagged domains (10 kDa, 16 kDa and 30 kDa overlays) and binding detected with polyclonal rabbit anti-4.1R antibody using 
a chemiluminescent substrate. All the 4.1R fragments were detectable using the primary polyclonal antibody as demonstrated 
by the positive controls on the overlays. The 4.1R overlay indicates that 6His-PfJ binds native 4.1R. Two independent experi-
ments (1 and 2) revealed specific interaction between 6His-PfJ and GST-10 kDa.Malaria Journal 2006, 5:100 http://www.malariajournal.com/content/5/1/100
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entry is proposed: Following initial attachment to the host
cell surface, the merozoite reorients to bring its apical end
in close contact with the host membrane [16]. An increase
in the parasite's intracellular calcium concentration sig-
nals the secretion of the microneme and rhoptry contents
onto the erythrocyte surface [36]. With the aid of a C-ter-
minal transmembrane domain, DBL proteins are translo-
cated from the micronemes onto the merozoite surface,
where the DBL binding domains interact with erythrocyte
receptors [37]. However, it is possible that full-length
invasion proteins or modified forms [38,39] interact with
the erythrocyte skeleton. This would be made possible
through the action of lipases and proteases from the
merozoite's apical organelles. These molecules are respon-
sible for initiating structural changes in the erythrocyte
membrane including skeletal and surface modifications
[31,40-42]. It is therefore likely that the cleavage of pro-
teins and phospholipids on the erythrocyte membrane
during invasion will facilitate the transient access of EBA-
181 to 4.1R.
Histidine pull-down assays of GST-4.1R recombinant proteins Figure 3
Histidine pull-down assays of GST-4.1R recombinant proteins. A) 6His-PfJ bound specifically to GST-10 kDa in a histi-
dine pull-down assay. The interaction was dose-dependent and reliant on native GST-10 kDa protein conformation. M, eryth-
rocyte membrane marker; -ve, negative control pull-down using 5 μg heat denatured GST-10 kDa and +, assays indicating the 
dose-dependent nature of the interaction (+/++/+++ ≈ 150 ng/400 ng/800 ng GST-10 kDa respectively). B) 6His-PfJ (~800 ng) 
did not bind specifically to ~6 μg GST-16, 22 and 30 kDa proteins. 1, purified GST-4.1R domain; 2, histidine pull-down using 
heat denatured recombinant protein and 3, pull-down using non-denatured protein.Malaria Journal 2006, 5:100 http://www.malariajournal.com/content/5/1/100
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Conclusion
The intimate interaction between P. falciparum and the
erythrocyte membrane has provided fascinating insight
into the cell biology of the malaria parasite. The interac-
tion of EBA-181 with the highly conserved 10 kDa
domain in 4.1R highlights the complex role of microneme
invasion proteins. These proteins may potentially serve
multiple functions to mediate parasite entry into the
erythrocyte, including: 1) the initiation of merozoite inva-
sion by binding specific erythrocyte membrane receptors;
2) the destabilization of spectrin-actin interactions and
framework of the erythrocyte skeleton as a consequence of
binding to 4.1R, and 3) EBA-181 may inhibit potential
host membrane repair pathways.
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